However, mRNA and protein expression of MTA3 were significantly downregulated in esophageal squamous cell carcinoma and esophagogastric adenocarcinoma, a finding consistently validated across multiple independent databases and clinical cohorts (50, 51). The gene discussed is MTA3; the disease is gastroesophageal junction adenocarcinoma.